EDX — Edx Medical Share Price
Last trade - 00:00- £27.80m
- £24.96m
- £0.33m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 12.84 | ||
| Price to Tang. Book | 13.72 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 84.1 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -267.69% | ||
| Return on Equity | -242.99% | ||
| Operating Margin | -1767.9% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | n/a | 0 | 0.23 | 0.12 | 0.33 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
EDX Medical Group Plc is a United Kingdom-based company, which develops digital diagnostic products and services for the personalized treatment for cancer, heart disease and infectious diseases. The Company provides healthcare professionals and organizations with tools and services for predicting and managing diseases on a personalized basis. It provides tests for use by professionals or individuals at point-of-care, home, or workplace. Its products and services include Caris MI Profile, cResponse, Caris MI Tumor Seek Hybrid, Caris Assure, Testicular cancer testing, Prostate cancer super test, Bowel cancer super test, Multiple biomarker 5FU/ capecitabine pharmacogenomic drug safety and treatment management test, and Polymerase chain reaction (PCR) test, among others. The Caris MI Profile platform offers artificial intelligence (AI) solutions such as Caris GPsai and Caris FOLFIRSTai to guide clinicians in diagnosis and treatment of cancer patients.
Directors
- Christopher Evans EDR (68)
- Michael Hudson CEO
- Trevor Jones NID (81)
- Martin Walton VCH (62)
- Michael Owen NEC (75)
- Last Annual
- March 31st, 2026
- Last Interim
- March 31st, 2026
- Incorporated
- March 19th, 2021
- Public Since
- June 3rd, 2021
- No. of Employees
- 24
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 411,844,583
- Address
- 211 Cambridge Science Park, Milton Road, CAMBRIDGE, CB4 0WA
- Web
- https://edxmedical.co.uk
- Phone
- Auditors
- PKF Littlejohn LLP
Similar to EDX
Chill Brands
London Stock Exchange
CVS
London Stock Exchange
Hellenic Dynamics
London Stock Exchange
Imaging Biometrics
London Stock Exchange
Integrated Diagnostics Holdings
London Stock Exchange
FAQ
As of Today at 10:23 UTC, shares in Edx Medical are trading at 6.75p. This share price information is delayed by 15 minutes.
Shares in Edx Medical last closed at 6.75p and the price had moved by over the past 365 days. In terms of relative price strength the Edx Medical share price has matched the FTSE All Share Index by over the past year.
There is no consensus recommendation for this security.
Find out moreEdx Medical does not currently pay a dividend.
Edx Medical does not currently pay a dividend.
Edx Medical does not currently pay a dividend.
To buy shares in Edx Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 6.75p, shares in Edx Medical had a market capitalisation of £27.80m.
Here are the trading details for Edx Medical:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: EDX
Based on an overall assessment of its quality, value and momentum Edx Medical is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Edx Medical. Over the past six months, its share price has matched the FTSE All Share Index by .
As of the last closing price of 6.75p, shares in Edx Medical were trading -28.44% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Edx Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 6.75p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Edx Medical's management team is headed by:
- Christopher Evans - EDR
- Michael Hudson - CEO
- Trevor Jones - NID
- Martin Walton - VCH
- Michael Owen - NEC